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ABSTRACT
Background    Endoscopy of the digestive tract is useful 
but is associated with significant pain to the patient. Its 
safety and tolerability could be improved by an immedi-
ate and objective method to evaluate the pain level and 
give feedback to the examiner. However, under the cur-
rent circumstances, it is difficult to measure and assess 
the pain level objectively. 
Methods    We previously developed a discomfort 
assessment device that measures the changes in brain 
activity caused by changes in the pain level by extracting 
the changes in the erythema index from facial color 
data. In this study, to evaluate the usefulness of this 
discomfort assessment device, the association between 
the changes in the erythema index of facial images 
during colonoscopy and the subjective pain level during 
the examination were evaluated. For the recording 
of the subjective pain level during the examination, a 
subjective pain level recording device that we developed 
to measure grip strength over time was used. The sub-
jective pain level, facial image, and percutaneous venous 
oxygen saturation during the examination were recorded 
in 30 patients who underwent colonoscopy at our hospi-
tal. 
Results    The duration of colonoscopy was divided into 
the insertion section and the removal section. The sub-
jective pain level was found to be significantly greater 
during the insertion section than during the removal 
section, and the changes in the erythema index of the 
facial images were significantly different between the 
two groups. 
Conclusion    These findings indicate that the erythema 
index changes on facial images determined by the 
discomfort assessment device may facilitate objective 
evaluation of the pain level during colonoscopy.
Key words    autonomic nerve, brain wave, colonoscopy, 
erythema, pain measurement
The prevalence of malignant gastrointestinal tumors is 
increasing as the population ages. To detect and treat 
such tumors at an early stage, the necessity of exam-
ination and treatment using gastrointestinal endoscopy 
(hereinafter referred to as “endoscopy”) continues to 
rise. However, significant physical and mental pain is 
associated with endoscopy, and this significant pain 
is one of the reasons why colonoscopy in particular is 
often evaded. In this manuscript, “pain level” refers to 
the degree of pain that alters brain activity and includes 
both physical and mental pain.
 In preventive screening for colorectal cancer, an 
immunochemical fecal occult blood test is used as the 
primary test. This test is the non-invasive and convenient 
portion of the screening. The secondary test, however, 
involves significant pain because a comprehensive ex-
amination with colonoscopy is performed. According to 
a survey by the Japan Cancer Society, the rate of under-
going comprehensive screening in FY2015 was 91.0% 
for breast cancer, 83.9% for cervical cancer, 80.7% for 
gastric cancer, 79.8% for lung cancer, and 70.8%, the 
lowest, for colorectal cancer.1
 The plausible factors for this include the physical 
pain associated with the pre-treatment for endoscopy, 
as well as during the endoscopy, and the mental pain 
caused by shame. Although the pain level during endos-
copy is dependent on the examiner’s technique, there 
are no devices or methods that can give instantaneous 
feedback on the pain level during the examination. The 
pain level is expressed as the subjective pain level or the 
objective pain level depending on the person in charge of 
its evaluation. In this article, the subjective pain level is 
the pain level expressed by the participants themselves. 
The objective pain level is defined as the pain level that 
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can be acquired from the participants’ external signs 
without depending on them to express it.
 There are several methods for evaluating physical 
pain through the measurement of substances that 
change with the physical stress response. These include 
measuring salivary amylase and plasma catecholamine, 
vasopressin, and adrenaline concentrations, as well 
as urine cortisol excretion.2, 3 However, these methods 
are cumbersome and cannot provide instantaneous 
results. Moreover, although a visual analog scale is used 
as a scale to evaluate subjective pain, it is also not an 
immediate or an objective approach. The method that 
evaluates the autonomic function state from temporal 
fluctuations in the pulse is convenient and gives immedi-
ate results, but it does not directly assess the pain level.4
 Since pain affects brain activity,5, 6 the evaluation of 
the objective pain level would be possible by objectively 
ascertaining the differences in brain activity at time 
points in which there is significant pain and minimal 
pain. Although electroencephalography, Near-Infrared 
Spectroscopy, and Functional Magnetic Resonance 
Imaging may be able to measure brain activity, they all 
involve the use of a sensor probe, as well as large-scale 
instruments, and they are not suitable for evaluating the 
objective pain level during endoscopy.
 As a device that is capable of measuring brain ac-
tivity in a noncontact fashion, there is one that estimates 
brain activity based on facial skin temperature data from 
thermography.7 However, thermography is typically 
expensive and is difficult to market if it is incorporated 
into a medical instrument. Previous reports have shown 
the association of brain activity with cerebral blood 
flow and with facial blood flow caused by cerebral 
blood flow.8–12 Based on these reports, we developed an 
algorithm for a noncontact brain activity sensing system 
that estimates the changes in brain activity from changes 
in the erythema index on facial images.13 We then de-
veloped a discomfort assessment device to investigate 
the validity of the sensing technique for evaluating the 
objective pain level.14 The discomfort assessment device 
is composed of a color video camera with a complemen-
tary metal-oxide-semiconductor sensor and software 
for the noncontact brain activity sensing system, which 
estimates brain activity from facial images.13
 In this study, the association between the output data 
from this discomfort assessment device and the patient’s 
subjective pain level during colonoscopy was examined 
to investigate the usefulness of the noncontact brain ac-
tivity sensing system and discomfort assessment device.
MATERIALS AND METHODS
Ethics
This study was conducted at the Advanced Medicine, 
Innovation and Clinical Research Center, Tottori University 
Hospital, Yonago, Japan. The study was approved by the 
Tottori University Ethics Committee (no. 1610B057) and 
registered in UMIN-CTR (no. UMIN000035052).
Study participants
This study included men and women, ≥ 20 years old, who 
were outpatients or inpatients at the Gastroenterology 
Department of Tottori University Hospital between 
December 2016 and September 2018 and were scheduled 
to undergo medically-indicated colonoscopy. Patients who 
were deemed unsuitable to participate in the study by the 
attending physician or principal investigator were exclud-
ed.
Equipment and instruments
Subjective pain level recording device: Temporal grip-
ping strength measurement device (Tottori University 
Hospital).
 Discomfort assessment device (Fig. 1)14: Analysis 
software (noncontact brain activity sensing system)13 and 
Color video camera (HX-A1H-K, Panasonic, Osaka, 
Japan).
 Pulse oximeter: Percutaneous oxygen saturation 
measurement device (Pulsfit MP-1000, Japan Precision 
Instruments, Shibukawa, Japan).
Measurement of the subjective pain level during 
colonoscopy
To evaluate the subjective pain level of the study partici-
pants, a subjective pain level recording device was used. 
This device records the changes in the participant’s grip 
strength throughout the colonoscopy and is composed of 
a gripping device and a computer that records the grip 
strength over time.
 The maximum grip strength of the study partic-
ipants was recorded in the internal memory of the 
device. The change in grip strength from the initial state 
to maximum grip strength was designated as the re-
cording range of the subjective pain level for each study 
participant, and its percentage was shown on the number 
display. Participants were instructed to hold the device 
throughout the examination and to change the grip in 
accordance with the pain level when they felt pain. The 
number was defined as the subjective pain level and was 
recorded in the internal memory of the device over time. 
The device was positioned such that the examiner could 
not view the numerical display.
 The maximum value of the subjective pain level was 
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set prior to the endoscopy based on the measurements 
obtained from the subjective pain level recording device. 
When the subjective pain level obtained during the 
examination exceeded the pre-set maximum value, the 
recording range was corrected with the exceeded value 
as the new maximum, and the data obtained in all sec-
tions were normalized accordingly.
 The point when the tip of the endoscope enters the 
cecum was specifi ed as the time point of reaching the 
deep area, and from the start of the examination to this 
point was defi ned as the “insertion section,” and from 
this point to the conclusion of the examination was de-
fi ned as the “removal section.” Formulas for determining 
subjective pain level are as follows: the section average
participant remained constant. Measurement recoding 
conditions were: frame rate, 30 frames per second; res-
olution, 1920 × 1080 pixels; compression format, H.264 
(MPEG-4 AVC); and bit rate, approximately 15 Mbps.15
 Endoscope operation and changes in the partici-
pant’s state, such as body movement or shift in body po-
sition during the examination, were recorded on audio. 
 Figure 2 shows the designated area for analysis 
on the study participants’ facial images. The area is 
enclosed by the outer corners of the eyes, immediately 
under the lower lid, and immediately above the upper 
lip. The red, green, and blue values (8-bit color depth) 
contained in each pixel in the designated area of all im-
age frames. The equation and formulas for determining 
the erythema index, its section average value and vari-
ations value are as follows:  for determining erythema 
index a*, a conversion equation from the RGB value to 
the erythema index is done (CIE-L*a*b* color system)16:
CMOS camera
White LED lighting
Head mount
Fig. 1. Illustration of discomfort assessment device (color 
video camera, white LED lighting, and head mount). CMOS, 
Complementary Metal Oxide Semiconductor; LED, light emitting 
diode.
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Facial image acquisition and erythema index cal-
culation using the discomfort assessment device
The face of the study participant during the colonoscopy 
was captured with a color video camera and recorded 
as a video fi le. To eliminate the effects o  ambient light, 
ring-shaped white LED lig ting was placed around the 
color video camera and fi xed to each study participant’s 
head with the head mount. Conditions were specified 
such that the positional relationship between the light 
source, color video camera, and facial area of the study 
Left corner of the eyeRight corner of the eye
Under the lower eyelid
Above the upper lip
Fig. 2. The ROI set for the discomfort assessment device is indi-
cated by the gray area in the ﬁ gure. The area is enclosed by the 
outer corners of the eyes, under the lower lid, and above the upper 
lip. ROI, region of interest.
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The mean erythema index of each pixel for each frame 
within the designated area was determined to generate a 
time series waveform of the changes.
 The present investigation showed that there are 
individual differences in the changes in erythema index 
from heart rate fluctuations, even in the resting state. 
This was thought to reflect the individual difference 
in skin tone and variations in ambient light. For this 
reason, the erythema index was corrected for each par-
ticipant using the range of the erythema index caused by 
heart rate fl uctuations. The data processing fl ow chart is 
shown below (Fig. 3). 
Recording of percutaneous oxygen saturation 
over time
Percutaneous oxygen saturation was measured using a 
pulse oximeter (MP-1000, Japan Precision Instruments). 
The device was worn on the right index fi nger, and the 
recording frequency was 25 Hz.
Collected data
This study investigated patients who gave their written 
consent to participate in the study after receiving a thor-
ough explanation using a consent form approved by the 
Tottori University Ethical Review Board.
 None of the 30 study participants were excluded by 
the attending physician or by the study participant.
 The subjective pain level could be recorded in 11 of 
30 participants. Excluded participants were those with 
data recording failure from failure to operate the device 
correctly or to set the time.
 Facial images from the discomfort assessment 
device could be acquired in 25 of 30 participants. Those 
who were excluded had data that were not suitable for 
analysis due to body movement or poor camera stabili-
zation. Furthermore, one case was excluded because the 
time point of reaching the deep area was unknown due 
to device battery depletion. Two participants whose anal-
ysis sections could not be set up due to body movement 
noise around the point of reaching the deep area were 
excluded, and 22 of 24 participants were investigated.
 Percutaneous oxygen saturation could be obtained 
in 12 of 30 participants. Excluded participants were 
those who failed to wear the sensor or those with device 
battery depletion. Analysis was conducted with the data 
of 10 of 12 participants. One participant was excluded 
due to missing facial image data for analysis, and anoth-
er was excluded because the time point of reaching the 
deep area could not be determined.
Statistical analysis
References for subjective pain level and erythema index 
between the insertion section and removal section during 
colonoscopy used a paired t test for continuous vari-
ables. We used the R 3.5.0 (R Development Core Team, 
Auckland, New Zealand) to perform all the statistical 
analyses.
Start 
Take video during colonoscopy 
To Analysis 1 
Measurement 
Down-sampling of the mean data 
to every second 
Calculate the mean and standard 
deviation of the insertion section 
Calculate the mean and the 
standard deviation of the removal 
section 
Analysis 3:  
Statistical processing 
Apply the band-pass filter to the 
erythema index waveform for the 
one-minute duration of the 
resting state, with a cut-off 
frequency of 0.75-3 Hz 
Extract and convert data outliers 
with the MATLAB filloutliers 
function 
Calculate the envelope and 
determine the difference between 
the upper envelope and the lower 
envelope with the MATLAB 
envelope function 
Calculate the mean erythema 
index in the ROI of one frame 
Designate the median of the 
insertion and removal sections of 
the difference as the heart rate 
amplitude 
Analysis 2: 
 Correction for fluctuations 
To Analysis 3 
Specify ROI of the video 
Extract the RGB component of 
the starting frame of the video 
Convert the RGB component to 
the erythema index 
Calculate the mean erythema 
index in the ROI of one frame 
Repeat from the beginning to the 
end of the video 
Designate the noiseless section 
before reaching the deep area as 
the insertion section 
Designate the noiseless section 
after reaching the deep area as 
the removal section 
Analysis 1:  
Quantification of facial skin tone 
To Analysis 2 
Repeat from the beginning to the 
end of the video 
Conclusion 
Fig. 3. Data processing ﬂ ow chart for calculating the facial erythema index. MATLAB is a multi-paradigm numerical computing envi-
ronment and proprietary programming language developed by MathWorks. RGB, Red Green Blue; ROI, region of interest.
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RESULTS
 The erythema index was a numerical value having no 
unit. Therefore, it was diffi cult to directly compare with 
the subjective pain level expressed in percentage. We 
compared the erythema index and the subjective pain 
level in the insertion section and in the removal section 
during colonoscopy, respectively. 
Comparison of the subjective pain level in the in-
sertion section and in the removal section during 
colonoscopy
A time series waveform for changes in the subjective 
pain level was generated for every participant.
 Figure 4a shows an example of the measurement of 
the subjective pain level. During the insertion section 
of colonoscopy, intermittent gripping was prominent. 
Compared to the removal section, both the number of 
grips and grip strength were greater, indicating that the 
subjective pain level was greater during the insertion 
section compared to the removal section. 
 The mean subjective pain level and amount of varia-
tion (also defi ned as standard deviation) were compared 
between the insertion section and removal section; both 
were signifi cantly greater in the insertion section com-
pared to the removal section  (Figs. 4b and c).
Comparison of the facial erythema index obtained 
from the discomfort assessment device between 
the insertion section and the removal section 
during colonoscopy
Figure 5a shows an example of the time series waveform 
for the changes in the facial erythema index. A signif-
icant change in the numerical value is observed when 
there is a shift in body position during colonoscopy. The 
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(a) Typical subjective pain level waveforms obtained from subjective pain level recording device
(b) Comparison of section average values (c) Comparison of section variation values
Fig. 4. (a) Typical pain level waveforms by the colonoscopy operation. Dotted line indicates the time point of reaching the deep area, and 
from the start of the examination to this point was deﬁ ned as the “insertion section (dark gray area),” and from this point to the conclu-
sion of the examination was deﬁ ned as the “removal section (light gray area).” In this patient there is a waveform peak in the range of 
insertion section. (b) Scattered diagram of mean of pain level score at insertion and removal section. Signiﬁ cant difference was observed 
between the insertion section and the removal section. (n = 10, *P = 0.014) (c) Scattered diagram of variation (standard deviation) of pain 
level score at insertion and removal section. Signiﬁ cant difference was observed between the insertion section and the removal section. 
(n = 10, *P = 0.030)
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shaded areas indicate the analyzed sections. The sections 
were defi ned as a period from the time point of reaching 
the deep area until, both forward and backward, the time 
point in which there appeared a clear external factor due 
to changes in lighting caused by a shift in body position. 
The analysis was conducted only in the sections in 
which the participant was in a supine position.
 For the facial erythema index acquired from the 
discomfort assessment device, the mean and amount of 
variation (standard deviation) were calculated for each 
section (insertion and removal) to determine statistical 
signifi cance (Figs. 5b and c).
 The mean was not significantly different between 
the two groups, and the trend for an increase or decrease 
was unknown. The standard deviation was signifi cantly 
greater for the insertion section than the removal section. 
Comparison of heart rate obtained from the 
facial image and from the percutaneous oxy-
gen saturation waveform
The changes in the facial erythema index represent 
the changes in facial blood fl ow.16 Using the technique 
developed by McDuff et al. that estimates the heart rate 
from facial images,17 a band-pass fi lter (0.75-3 Hz) was 
applied to the erythema index waveform, and the peaks 
were determined from the resulting waveform. The 
estimated heart rate was determined using the peak per 
10 seconds. Table 1 shows the comparison of heart rate 
measured by pulse oximetry and by the facial erythema 
index waveform. These data were obtained simultane-
ously. The formulas for determining the  concordance 
rate of the mean heart rate of each section between the 
two measurement methods are as follows: the concor-
dance rate YC is YC
M. Fujii et al., P. 8 
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(a) Typical erythema index waveforms obtained from discomfort assessment device
(b) Comparison of section average values (c) Comparison of section variation values
Fig. 5. (a) Change in color tone of face measured by discomfort assessment device during the colonoscopy operation. Dotted line indi-
cates the time point of reaching the deep area, and from the start of the examination to this point was deﬁ ned as the “insertion section 
(dark gray area)”, and from this point to the conclusion of the examination was deﬁ ned as the “removal section (light gray area).” The 
data acquired in both gray areas were used for analysis, while the patient’s posture was supine. (b) Scattered diagram of mean of facial 
erythema index at insertion and removal section. There was no signiﬁcant difference in the insertion section and the removal section. 
(n = 22, *P = 0.278) (c) Scattered diagram of variation (standard deviation) of facial erythema index at insertion and removal section. 
Signiﬁ cant difference was observed between the insertion section and the removal section. (n = 22, *P = 0.002)
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average value of the heart rate (bpm) by facial erythema 
index, and YP = the section average value of the heart 
rate (bpm) by pulse oximetry.
 The average concordance rate (%) was 95.4% for 
the insertion section and 97.4% for the removal section. 
Based on these results, the heart rate obtained from the 
changes in the facial erythema index was used in the 
evaluation.
DISCUSSION
In this study, the subjective pain level was shown ex-
perimentally to be significantly greater in the insertion 
section than in the removal section during colonoscopy 
(Figs. 4a–c).
 The facial erythema index standardized by the 
changes in the erythema index from changes in the heart 
rate in the insertion section and the removal section was 
investigated. For the average value a*A of the erythema 
index for each section, we set the average value of the 
erythema index in the insertion section to a*Ai and the 
average value of the erythema index in the removal sec-
tion to a*Ar. When “a*Ar - a*Ai > 0”, we called it “increased 
group”; “a*Ar - a*Ai < 0” was called “decreased group”; 
and “a*Ar - a*Ai = 0” was “invariant group.” Of these, 
“invariant group” was not recognized. It was found that 
there were cases in which the erythema index increased 
with decreased pain, and there were also cases that 
showed the opposite trend. It was difficult to directly 
compare the erythema index and the subjective pain 
level because the erythema index varies in properties de-
pendent on the subject and measurement conditions. The 
amount of change of the erythema index was very small 
compared to the absolute value. This was the reason 
why there was no significant difference in the average 
value. For this reason, a significant difference in the 
mean value was not observed between the two sections; 
however, differences in the size of the amplitude and 
in the number of fluctuations in the waveform were ob-
served. Therefore, the standard deviation was calculated 
as the amount of variation, and it was found that the 
fluctuations were significantly greater in the insertion 
section than in the removal section (Fig. 5c). These find-
ings indicated that the facial erythema index from pain 
can be used as an indicator of the objective pain level 
by using the standard deviation within the section. This 
study is a preliminary study investigating an evaluation 
method for an erythema index. Further experiments and 
studies are necessary to understand the mechanisms that 
alter variability of the erythema index.
 A change in the autonomic function state may also 
be a factor that alters the facial erythema index, since 
changes in facial blood flow can be induced from dilation/
constriction of facial surface blood vessels, as well as 
changes in heart rate. Therefore, the facial erythema 
index can be viewed as a mixture of components that 
reflect changes in brain activity, as well as the autonomic 
function state.
 In the current investigation, a decreased pain level 
led to an increase in the facial erythema index in some 
participants and a decrease in other participants, indicat-
ing the absence of a specific trend. We hypothesized that 
these modulations reflected the changes in the autonom-
ic function state. To test this hypothesis, the changes in 
the autonomic function state were analyzed based on the 
heart rate and temporal fluctuations in the pulse, albeit 
in a limited number of cases.
 The heart rate waveform determined from the facial 
erythema index was deconstructed by frequency through 
spectral analysis, and the size of the fluctuation of each 
frequency component was expressed as numerical 
Table 1. Concordance rate (%) between the heart rate obtained from the facial erythema index waveform and 
from the percutaneous oxygen saturation waveform
ID Heart rate (bpm) by pulse oximetry Heart rate (bpm) by facial erythema index Concordance rate (%)
Insertion Removal Insertion Removal Insertion Removal
16 95.36 84.14 91.02 88.22 95.40% 95.40%
17 66.11 65.76 66.85 66.85 98.90% 98.40%
20 80.10 82.27 80.43 81.35 99.60% 98.90%
21 84.12 85.62 82.86 85.66 98.50% 100.00%
22 89.83 103.32 104.28 108.20 86.10% 95.50%
25 56.16 56.41 65.49 61.33 85.70% 92.00%
26 61.75 56.58 63.34 58.12 97.50% 97.30%
27 70.80 71.87 71.38 71.60 99.20% 99.60%
28 58.75 56.53 62.00 56.75 94.80% 99.60%
29 62.80 60.60 63.72 62.01 98.60% 97.70%
Average 95.40% 97.40%
ID, subject identification number.
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Table 2. Comparisons of mean heart rates and LF/HF ratios in the group with an increased mean erythema index
ID Group with an increased mean erythema index (insertion section < removal section)
Mean heart rate Mean LF/HF
Insertion Removal Change Insertion Removal Change
6 104.35 105.22 0.87 0.30 0.26 –0.04
8 63.62 65.33 1.71 0.56 0.58 0.02
9 88.36 89.00 0.64 0.32 0.49 0.17
10 91.10 89.51 –1.59 0.33 0.40 0.07
12 92.80 91.41 –1.39 0.50 0.36 –0.14
13 95.13 98.12 2.99 0.23 0.17 –0.07
15 82.26 80.74 –1.53 0.15 0.05 –0.09
17 66.85 66.85 0.00 0.23 0.24 0.01
20 80.43 81.35 0.92 0.18 0.21 0.03
23 84.48 87.44 2.96 0.32 0.13 –0.19
24 84.67 86.10 1.43 0.28 0.15 –0.14
25 65.49 61.33 –4.16 0.55 0.60 0.05
26 63.34 58.12 –5.22 0.49 0.44 –0.05
27 71.38 71.60 0.23 0.14 0.13 –0.00
t-test P = 0.41 P = 0.17
Average –2.14 –0.03
HF, high frequency; ID, subject identification number; LF, low frequency. 
Table 3. Comparisons of mean heart rates and LF/HF ratios in a group with a decreased mean erythema index
ID Group with a decreased mean erythema index (insertion section < removal section)
Mean heart rate Mean LF/HF
Insertion Removal Change Insertion Removal Change
5 74.60 78.71 4.11 0.17 0.22 0.04
7 69.01 74.94 5.94 0.29 0.11 –0.19
11 86.69 88.12 1.43 0.31 0.36 0.05
14 88.42 88.22 –0.21 0.51 0.54 0.02
16 91.02 88.22 –2.80 0.39 0.61 0.22
21 82.86 85.66 2.80 0.21 0.20 –0.01
22 104.28 108.20 3.92 0.49 0.54 0.04
28 62.00 56.75 5.25 0.67 0.86 –0.19
29 63.72 62.01 1.71 0.59 1.41 –0.82
t-test P = 0.24 P = 0.10
Average 2.46 –0.09
HF, high frequency; ID, subject identification number; LF, low frequency. 
values.18 Fluctuation corresponding with the respiratory 
cycle with a relatively high frequency is designated as 
high frequency (HF), and fluctuation at a low frequency 
corresponding to the blood pressure cycle is designated 
as low frequency (LF). By calculating the LF/HF ratio, 
the autonomic function state can be assessed.4 A large 
LF/HF ratio indicates sympathetic dominance, while a 
low LF/HF ratio indicates parasympathetic dominance.
 The participants were divided into two groups based 
on the increase or decrease in the facial erythema index. 
For each group, the increase group and the decrease 
group, the association between each section was exam-
ined for the mean heart rate and LF/HF ratio. The results 
are shown in Tables 2 and 3. There were no significant 
differences between any combination of two groups 
for the mean heart rate and LF/HF ratio of the increase 
group and the mean heart rate and LF/HF ratio of the 
decrease group, indicating the absence of a specific 
trend or association. 
 Based on the study results, the changes in the auto-
nomic function state, compared to changes in the pain 
level, have a relatively small effect on the changes in 
the facial erythema index, suggesting that they can be 
disregarded, since they do not exhibit a specific trend. 
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However, the number of analyzed participants was lim-
ited, indicating the necessity to accumulate more data 
and perform further investigations. If the objective pain 
level could be immediately assessed during endoscopy, 
it would be possible to provide a safer and more com-
fortable examination. In particular, colonoscopy is con-
sidered to involve multiple pain-increasing factors, such 
as extension of the sigmoid colon at insertion or bloating 
from air insufflation. Moreover, because the pain level 
changes over time, an instantaneous assessment would 
be especially useful.
 This study demonstrated that the standard deviation 
of the facial erythema index is significantly greater 
during the insertion section, which involves a greater 
pain level. The immediate assessment of the objective 
pain level is clinically significant from the perspective 
of objectively evaluating the examiner’s technique and 
from the standpoint of improving the technique to lower 
the patients’ pain level during endoscopy.
 The results of this study suggested that the dis-
comfort assessment device that was developed may 
be capable of providing an objective assessment of the 
pain level associated with colonoscopy. This discomfort 
assessment device evaluates the facial erythema index 
from images taken with a color video camera and an 
algorithm using a noncontact brain activity sensing sys-
tem.
LIMITATIONS
Evaluations in this study were limited to the conditions 
used in colonoscopy and did not include other types of 
endoscopy.
 This study also did not take into consideration how 
butyl scopolamine bromide, given to study participants 
as an antispasmodic for endoscopy, may affect the auto-
nomic nervous system.
 Data on the LF/HF ratio do not include respiratory 
rate assessment.
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